Effector Therapeutics Inc (EFTR) — Cash Flow Reinvestment Rate
Effector Therapeutics Inc (EFTR) has a Cash Flow Reinvestment Rate of 0.00x as of June 2020, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $11.98 Million. See EFTR cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Effector Therapeutics Inc Cash Flow Reinvestment Rate (2020–2020)
Historical reinvestment intensity for Effector Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see Effector Therapeutics Inc (EFTR) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Effector Therapeutics Inc (2020–2020)
Year-by-year capital reinvestment analysis for Effector Therapeutics Inc. See EFTR financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.02x | $308.00K | $13.84 Million | $154.00K | — |